Clinical Trial Update: Angiotensin 2 for AKI After OLT [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Angiotensin II for acute kidney injury following orthotopic liver transplantation; enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• End-stage Liver Disease
• Kidney Injury

Drugs mentioned

• Angiotensin II (angiotensin II)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Cirrhosis, Liver, End Stage Liver DIsease | Phase 4 | Status: ENROLLING_BY_INVITATION